- Home
- ACDC vs CDTX Comparison
ACDC vs CDTX Comparison
Compare ACDC & CDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACDC
- CDTX
- Stock Information
- Founded
- ACDC 2014
- CDTX 2012
- Country
- ACDC United States
- CDTX United States
- Employees
- ACDC N/A
- CDTX N/A
- Industry
- ACDC Oilfield Services/Equipment
- CDTX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACDC Energy
- CDTX Health Care
- Exchange
- ACDC Nasdaq
- CDTX Nasdaq
- Market Cap
- ACDC 1.1B
- CDTX 980.1M
- IPO Year
- ACDC 2022
- CDTX 2015
- Fundamental
- Price
- ACDC $7.95
- CDTX $48.89
- Analyst Decision
- ACDC Hold
- CDTX Strong Buy
- Analyst Count
- ACDC 5
- CDTX 11
- Target Price
- ACDC $7.10
- CDTX $52.11
- AVG Volume (30 Days)
- ACDC 816.1K
- CDTX 1.4M
- Earning Date
- ACDC 08-07-2025
- CDTX 08-12-2025
- Dividend Yield
- ACDC N/A
- CDTX N/A
- EPS Growth
- ACDC N/A
- CDTX N/A
- EPS
- ACDC N/A
- CDTX N/A
- Revenue
- ACDC $2,209,700,000.00
- CDTX $302,000.00
- Revenue This Year
- ACDC N/A
- CDTX N/A
- Revenue Next Year
- ACDC $0.09
- CDTX N/A
- P/E Ratio
- ACDC N/A
- CDTX N/A
- Revenue Growth
- ACDC N/A
- CDTX N/A
- 52 Week Low
- ACDC $3.83
- CDTX $10.14
- 52 Week High
- ACDC $10.70
- CDTX $56.83
- Technical
- Relative Strength Index (RSI)
- ACDC 49.75
- CDTX 73.52
- Support Level
- ACDC $7.22
- CDTX $45.59
- Resistance Level
- ACDC $7.97
- CDTX $52.33
- Average True Range (ATR)
- ACDC 0.67
- CDTX 5.13
- MACD
- ACDC -0.14
- CDTX 0.22
- Stochastic Oscillator
- ACDC 29.32
- CDTX 61.27
About ACDC ProFrac Holding Corp.
ProFrac Holding Corp is engaged in providing hydraulic fracturing, completion services, and other complementary products and services to upstream oil and gas companies engaged in the exploration and production of North American unconventional oil and natural gas resources. Its operations are focused in West Texas, East Texas/Louisiana, South Texas, Oklahoma, Uinta, and Appalachian. The company operates in three segments: Stimulation Services, Proppant Production, and Manufacturing. Stimulation services, which generate the majority of the revenue for the company operate a fleet of mobile hydraulic fracturing units and other auxiliary equipment that generates revenue by providing stimulation services.
About CDTX Cidara Therapeutics Inc.
Cidara Therapeutics Inc is developing immunotherapeutics designed to help improve the standard of care for patients facing serious diseases. Its clinical-stage asset is CD388, a DFC intended for influenza prophylaxis. The Company's portfolio comprises new approaches aimed at transforming existing treatment and prevention paradigms, including DFCs from its proprietary Cloudbreak platform targeting oncologic, viral and autoimmune diseases.